IDEX (NYSE:IEX) Releases Quarterly Earnings Results, Beats Estimates By $0.21 EPS

IDEX (NYSE:IEX) released its quarterly earnings results on Wednesday. The industrial products company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.21, FiscalAI reports. The firm had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.75 million. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The company’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.75 earnings per share. IDEX updated its Q2 2026 guidance to 2.070-2.120 EPS and its FY 2026 guidance to 8.350-8.550 EPS.

Here are the key takeaways from IDEX’s conference call:

• Q1 beat and guidance raised: IDEX reported organic sales up 5%, Adjusted EBITDA margin of 26% (+50 bps YoY) and orders +10% organically, and raised full?year organic growth to 3%–4% with Adjusted EPS now $8.35–$8.55.
• HST outperformance and backlog build: Health & Science Technologies drove momentum with orders +17% and organic revenue +11%, 100 bps margin expansion and a stronger backlog that management says increases visibility into growth into 2027 across data center, semiconductor and space & defense markets.
• Mixed performance in short?cycle segments — FMT and FSDP lagging: FMT orders were +9% but sales only +2% (margin down 10 bps) and FSDP orders fell 4% with sales down 1%; management is forecasting flattish growth for these segments, which limits near?term consolidated upside.
• Capital allocation and liquidity intact: IDEX repurchased $76M of stock in Q1 (plans to maintain quarterly pace), generated $86M FCF in the seasonally weak quarter, finished with ~2x gross leverage and an active bolt?on M&A pipeline while keeping buybacks and dividends.

IDEX Trading Up 5.6%

IDEX stock traded up $11.54 during mid-day trading on Wednesday, hitting $216.90. The company’s stock had a trading volume of 1,505,642 shares, compared to its average volume of 826,034. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.86 and a quick ratio of 2.02. The stock has a market cap of $16.13 billion, a price-to-earnings ratio of 33.84, a price-to-earnings-growth ratio of 2.10 and a beta of 0.99. The business has a 50 day moving average price of $198.78 and a 200-day moving average price of $187.55. IDEX has a 12 month low of $157.25 and a 12 month high of $223.85.

IDEX News Roundup

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX beat Q1 estimates and raised guidance — Q1 revenue was $886.9M (? +8.9% YoY) and adjusted diluted EPS was $2.00, topping expectations; management raised FY 2026 adjusted EPS guidance to $8.35–8.55 (above consensus) and gave Q2 EPS guidance of $2.07–2.12, which frames near?term momentum. Read More.
• Positive Sentiment: Management cited strong AI/data?center demand — Reuters highlights that elevated demand from AI and data?center customers helped justify the higher profit forecast, a secular tailwind that can sustain higher margins and growth. Read More.
• Positive Sentiment: Analyst targets and sentiment skew positive — recent analyst coverage shows multiple price targets above the current level (median near $241), implying upside if execution continues. That supportive research likely amplified investor buying after the beat. Read More.
• Neutral Sentiment: Earnings call / transcript available for deeper color — the investor presentation and call transcript give more detail on end?market demand, backlog, and margin drivers for active investors wanting to verify sustainability of the beat. Read More.
• Neutral Sentiment: Market activity and technicals — intraday volume is running above average and the stock is trading above both its 50? and 200?day moving averages, which can attract momentum flows; monitor volume if you’re timing entries/exits. Read More.
• Negative Sentiment: Institutional position shifts are mixed — while many funds hold IEX, some large managers reduced exposure heavily in the prior quarter (e.g., UBS AM), a sign that some large holders may take profits or rebalance into other themes. This could limit upside if selling resumes. Read More.

Institutional Trading of IDEX

Several hedge funds have recently added to or reduced their stakes in the business. Pacer Advisors Inc. lifted its position in IDEX by 4.9% in the fourth quarter. Pacer Advisors Inc. now owns 6,393 shares of the industrial products company’s stock valued at $1,138,000 after purchasing an additional 297 shares during the last quarter. Alberta Investment Management Corp bought a new stake in IDEX in the fourth quarter valued at approximately $1,406,000. Mercer Global Advisors Inc. ADV raised its stake in shares of IDEX by 55.5% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 9,572 shares of the industrial products company’s stock valued at $1,703,000 after acquiring an additional 3,415 shares during the last quarter. EP Wealth Advisors LLC bought a new position in shares of IDEX during the fourth quarter valued at about $210,000. Finally, Mackenzie Financial Corp raised its stake in shares of IDEX by 2.8% during the fourth quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company’s stock valued at $458,000 after acquiring an additional 70 shares during the last quarter. 97.96% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. DA Davidson upped their target price on IDEX from $180.00 to $195.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Oppenheimer reiterated an “outperform” rating and issued a $230.00 target price on shares of IDEX in a report on Thursday, February 5th. Argus upgraded shares of IDEX from a “hold” rating to a “buy” rating and set a $240.00 target price on the stock in a report on Friday, February 6th. Weiss Ratings restated a “hold (c)” rating on shares of IDEX in a report on Monday, April 20th. Finally, Citigroup lifted their price target on shares of IDEX from $202.00 to $243.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.90.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.